TREATMENT VARIATION COMPLICATES REAL-WORLD PHARMACOECONOMICS: DAILY CLINICAL PRACTICE OF BORTEZOMIB IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA

被引：1
|
作者：
Franken, M. [1 ]
Gaultney, J. [1 ]
Huijgens, P. [2 ]
Redekop, W. K. [1 ]
Uyl-de Groot, C. A. [1 ]
机构：
[1] Erasmus Univ, Med Ctr, Rotterdam, Netherlands
[2] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands
来源：
VALUE IN HEALTH | 2009年 / 12卷 / 07期
关键词：
D O I：
10.1016/S1098-3015(10)74098-5
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A225 / A225
页数：1
相关论文
共 50 条
  • [1] Bortezomib retreatment for relapsed and refractory multiple myeloma in real-world clinical practice
    Hulin, Cyrille
    de la Rubia, Javier
    Dimopoulos, Meletios A.
    Terpos, Evangelos
    Katodritou, Eirini
    Hungria, Vania
    De Samblanx, Hadewijch
    Stoppa, Anne-Marie
    Aagesen, Jesper
    Sargin, Deniz
    Sioni, Anastasia
    Belch, Andrew
    Diels, Joris
    Olie, Robert A.
    Robinson, Don, Jr.
    Potamianou, Anna
    van de Velde, Helgi
    Delforge, Michel
    [J]. HEALTH SCIENCE REPORTS, 2019, 2 (01)
  • [2] Bortezomib-based therapy for relapsed/refractory multiple myeloma in real-world medical practice
    Terpos, Evangelos
    Katodritou, Eirini
    de la Rubia, Javier
    Hungria, Vania
    Hulin, Cyrille
    Roussou, Maria
    Delforge, Michel
    Bries, Greet
    Stoppa, Anne-Marie
    Aagesen, Jesper
    Sargin, Deniz
    Belch, Andrew
    Ahlberg, Lucia
    Diels, Joris
    Olie, Robert A.
    Robinson, Don, Jr.
    Spencer, Mike
    Potamianou, Anna
    van de Velde, Helgi
    Dimopoulos, Meletios A.
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2018, 101 (04) : 556 - 565
  • [3] Bortezomib therapy in a real-world setting in patients with relapsed or refractory multiple myeloma
    Huang, Shang-Yi
    Chen, Tsai-Yun
    Kuo, Ching-Yuan
    Chen, Yeu-Chin
    Lin, Sheng-Fung
    Chang, Ming-Chih
    Lv, Xinzhu
    Yang, Betty
    Chang, Cheng-Shyong
    [J]. ONCOLOGY REVIEWS, 2019, 13 (01) : 15 - 22
  • [4] THE EFFICACY OF BORTEZOMIB AND BORTEZOMIB-CONTAINING REGIMENS FOR TREATMENT OF RELAPSED/REFRACTORY MULTIPLE MYELOMA IN REAL CLINICAL PRACTICE
    Mitina, T.
    Golenkov, A.
    Kataeva, E.
    Lutskaya, T.
    Trifonova, E.
    Klinushkina, E.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 576 - 576
  • [5] REAL-WORLD BORTEZOMIB USAGE PATTERNS AMONG PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
    Calkins, G.
    Kohansimeh, J.
    Krishna, A.
    Green, R. J.
    Curtis, M.
    Lindberg, F. P.
    Jaskiw, A.
    Larrabee, K.
    Terry, M.
    Feinstein, R. N.
    Plotkin, L.
    Palladino, M. L.
    Nicacio, L. Viana
    [J]. HAEMATOLOGICA, 2015, 100 : 742 - 742
  • [6] A glimpse into relapsed refractory multiple myeloma treatment in real-world practice in Spain: the GeminiS study
    Rios-Tamayo, Rafael
    Soler, Juan Alfons
    Garcia-Sanchez, Ricarda
    Persona, Ernesto Perez
    Arnao, Mario
    Garcia-Guinon, Antoni
    Domingo, Abel
    Gonzalez-Pardo, Miriam
    de la Rubia, Javier
    Mateos, Maria Victoria
    [J]. HEMATOLOGY, 2023, 28 (01)
  • [7] Real-World Practice Patterns with Carfilzomib in Patients with Relapsed and Refractory Multiple Myeloma
    Harvey, R. Donald
    Cong, Ze
    Werther, Winifred
    Lethen, Jan L.
    Lonial, Sagar
    [J]. BLOOD, 2014, 124 (21)
  • [8] Real-world effectiveness and safety of daratumumab, bortezomib, and dexamethasone in relapsed/refractory multiple myeloma in Slovakia
    Harvanova, L'ubica
    Stulajterova, Viera
    Guman, Tomas
    Ladicka, Miriam
    Hlebaskova, Monika
    Chudej, Juraj
    Simek, Miroslav
    Stecova, Natalia
    Flochova, Emilia
    Kubala, Jan
    Simancikova, Iveta
    Drgona, L'ubos
    Vranovsky, Andrej
    Wild, Alexander
    Mistrik, Martin
    Batorova, Angelika
    [J]. NEOPLASMA, 2021, 68 (03) : 626 - 630
  • [9] Real-World Treatment of Patients With Relapsed/Refractory Myeloma
    Ntanasis-Stathopoulos, Ioannis
    Gavriatopoulou, Maria
    Terpos, Evangelos
    Dimopoulos, Meletios A.
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (06): : 379 - 385
  • [10] Ixazomib, lenalidomide, and dexamethasone combination in "real-world" clinical practice in patients with relapsed/refractory multiple myeloma
    Sokol, Juraj
    Guman, Tomas
    Chudej, Juraj
    Hlebaskova, Monika
    Stecova, Natalia
    Valekova, Lubica
    Kucerikova, Monika
    Stasko, Jan
    [J]. ANNALS OF HEMATOLOGY, 2022, 101 (01) : 81 - 89
12345